Do beta‑blockers inhibit erections or ejaculation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Beta-Blockers Inhibit Erections or Ejaculation?

Some beta-blockers can cause erectile dysfunction, but the effect varies significantly by agent—older non-selective beta-blockers (propranolol, atenolol) are more likely to impair erectile function, while nebivolol may actually improve it through enhanced nitric oxide bioavailability. Regarding ejaculation, beta-blockers have been studied for delaying ejaculation in premature ejaculation treatment, though evidence is insufficient to recommend them for this purpose 1.

Effects on Erectile Function

Agent-Specific Differences Matter

The 2012 Princeton III Consensus explicitly states that nebivolol, which has direct vasodilating properties, is less likely to cause ED than other beta-blockers 2. The 2025 European Association of Urology guidelines classify beta-blockers among antihypertensives that may cause ED, but acknowledge substantial within-class heterogeneity 3.

The 2003 AACE guidelines note that "some β-adrenergic blocking agents may cause sexual problems" but are less problematic than older antihypertensives like reserpine or guanethidine 4. The mechanism involves either drug-specific effects or decreased systolic blood pressure leading to reduced intracavernosal penile pressure, particularly in patients with underlying microvascular disease 4.

Evidence Quality and Mechanisms

Recent systematic analyses demonstrate that only thiazide diuretics and beta-blockers (except nebivolol) adversely influence erectile function 5. A 2020 review confirms that older studies showed contradictory findings due to methodological errors in assessing erectile function, but more recent evidence unveils the negative impact of this drug class—with nebivolol as the sole exception 6.

The physiological mechanism involves testosterone reduction: a 1988 placebo-controlled study found significant reductions in total and free testosterone with all four tested beta-blockers (atenolol, metoprolol, pindolol, propranolol), with non-selective agents causing the greatest reduction 7.

The Hawthorne Effect

An important caveat: a 2009 randomized trial revealed that patient knowledge about potential ED side effects dramatically increases ED incidence (32% when fully informed vs. 8% when uninformed about the drug or side effects) 8. When ED occurred, placebo was as effective as tadalafil in reversing it, suggesting the etiology is largely psychological when patients are primed to expect this side effect 8.

Effects on Ejaculation

Beta-blockers have been investigated for treating premature ejaculation, not causing ejaculatory dysfunction. The 2004 AUA guideline on premature ejaculation notes that "phenoxybenzamine and propranolol have been studied, but the panel did not believe the evidence was sufficient to support a recommendation for their use" in delaying ejaculation 1. The rationale is that ejaculation involves the sympathetic nervous system, so adrenergic blockade could theoretically delay or inhibit ejaculation.

Clinical Approach

When prescribing antihypertensives to men concerned about sexual function:

  • Prefer nebivolol among beta-blockers if this class is indicated, as it may improve rather than impair erectile function through nitric oxide-mediated vasodilation 2, 6
  • Consider ACE inhibitors, angiotensin receptor blockers, or calcium channel blockers as alternatives—these have neutral or even positive effects on erectile function 5
  • Avoid combining beta-blockers with thiazide diuretics in sexually active men, as both classes can impair erectile function and effects may be additive 4
  • Counsel patients appropriately about realistic risks to avoid nocebo effects that can triple ED incidence 8

The 2018 AUA guideline on ED emphasizes that ED itself is a risk marker for cardiovascular disease as strong as smoking or family history of MI, so the diagnosis provides an opportunity to address cardiovascular risk factors comprehensively 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.